Related Experiment Video
Updated: Aug 5, 2026

09:15
Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model
Published on: November 5, 2011
Is the "salvaged-cell syndrome" myth or reality?
1Department of Surgery, Mills-Peninsula Hospital, Burlingame-San Mateo, California, USA.
American Journal of Surgery
|August 1, 1996
Summary
Intraoperative autotransfusion (IAT) rarely causes coagulopathy. Complex factors like shock and hypothermia, not IAT itself, likely trigger disseminated intravascular coagulation (DIC) and adult respiratory distress syndrome (ARDS).
Area of Science:
- Medical Science
- Surgical Innovation
- Critical Care Medicine
Background:
- Intraoperative autotransfusion (IAT) is suspected to cause coagulopathy.
- This study investigates the link between IAT and coagulopathy, including disseminated intravascular coagulation (DIC).
Purpose of the Study:
- To assess the hypothesis that intraoperative autotransfusion precipitates or aggravates coagulopathy.
- To determine the incidence of coagulopathy (DIC) and adult respiratory distress syndrome (ARDS) in patients undergoing IAT.
Main Methods:
- Retrospective database review of over 36,000 multispecialty cases of IAT.
- Analysis focused on the occurrence of DIC and ARDS in association with IAT over an 18-year period.
Main Results:
- The incidence of coagulopathy was low at 0.05%.
- 18 cases of DIC/ARDS were identified, primarily in patients with ruptured aneurysms, massive trauma, or complex cardiac surgery, all experiencing shock, hypothermia, and requiring extensive transfusions (mean 28 units).
- Mortality in these 18 cases was 100%.
Conclusions:
- Coagulopathy following IAT is infrequent.
- Shock, hypothermia, and massive transfusions are the likely triggers for DIC and ARDS, rather than the autotransfusion process itself.
- ARDS may result from reperfusion injury after ischemic events, often linked to multiorgan failure.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.

